Asia-Pacific Insulin Infusion Pumps Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Component (Pump Device, Infusion Set, and Reservoir) and Geography.

Market Snapshot

Picture1
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 0 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

  • The Asia-Pacific insulin infusion pumps market is expected to witness a CAGR of 6%, during the forecast period (2019-2024), due to the exponentially increasing diabetes population in the Asian region.
  • Patients with type-1 diabetes mostly use the insulin infusion pump. However, companies are also targeting patients with type-2 diabetes, in order to provide better healthcare facility and expand the market. Insulin pump reduces the burden of multiple daily injections. The diabetes epidemic in the Asia-Pacific region offers significant unmet needs and market opportunities.

Scope of the Report

The market is segmented by component (pump device, infusion set, and reservoir) and geography.

By Product (Value and Volume, 2012-2024)
Insulin Pump
Infusion Set
Reservoir
By Geography
Asia-Pacific
Japan (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
South Korea (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
China (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
India (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Australia (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Vietnam (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Malaysia (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Indonesia (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Philippines (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Thailand (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir
Rest of Asia-Pacific (Value and Volume, 2012-2024)
By Insulin Pump Device
By Infusion Set
By Reservoir

Report scope can be customized per your requirements. Click here.

Key Market Trends

Increasing Diabetic Population

  • Over the past few decades, Asian countries have witnessed an epidemic increase in diabetic patients. More than 60% of the diabetic population exists in developing countries.
  • Self-monitoring of blood glucose fails to monitor blood sugar level from time to time. Thus, there is a need for continuous glucose monitoring, along with an insulin pump for diabetes patients.
Picture1

China Accounts for the Highest Market Share in the Asia-Pacific Region

  • In the Asia-Pacific insulin infusion pumps market, China accounted for close to 72% of the market value, in 2018. By 2024, the insulin infusion pump market in China is likely to be valued at USD 0.9 billion.
  • Malaysia and Vietnam account for the highest CAGR of 7% and 6%, respectively, in the market studied.
Picture4

Competitive Landscape

  • Medtronic is the market leader, and is expected to maintain its position during the forecast period. 
  • January 2018:  Medtronic, a medical device company, plans to open the operation site in China, to cater to the diabetes epidemic in the country.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product (Value and Volume, 2012-2024)

      1. 5.1.1 Insulin Pump

      2. 5.1.2 Infusion Set

      3. 5.1.3 Reservoir

    2. 5.2 By Geography

      1. 5.2.1 Asia-Pacific

        1. 5.2.1.1 Japan (Value and Volume, 2012-2024)

          1. 5.2.1.1.1 By Insulin Pump Device

          2. 5.2.1.1.2 By Infusion Set

          3. 5.2.1.1.3 By Reservoir

        2. 5.2.1.2 South Korea (Value and Volume, 2012-2024)

          1. 5.2.1.2.1 By Insulin Pump Device

          2. 5.2.1.2.2 By Infusion Set

          3. 5.2.1.2.3 By Reservoir

        3. 5.2.1.3 China (Value and Volume, 2012-2024)

          1. 5.2.1.3.1 By Insulin Pump Device

          2. 5.2.1.3.2 By Infusion Set

          3. 5.2.1.3.3 By Reservoir

        4. 5.2.1.4 India (Value and Volume, 2012-2024)

          1. 5.2.1.4.1 By Insulin Pump Device

          2. 5.2.1.4.2 By Infusion Set

          3. 5.2.1.4.3 By Reservoir

        5. 5.2.1.5 Australia (Value and Volume, 2012-2024)

          1. 5.2.1.5.1 By Insulin Pump Device

          2. 5.2.1.5.2 By Infusion Set

          3. 5.2.1.5.3 By Reservoir

        6. 5.2.1.6 Vietnam (Value and Volume, 2012-2024)

          1. 5.2.1.6.1 By Insulin Pump Device

          2. 5.2.1.6.2 By Infusion Set

          3. 5.2.1.6.3 By Reservoir

        7. 5.2.1.7 Malaysia (Value and Volume, 2012-2024)

          1. 5.2.1.7.1 By Insulin Pump Device

          2. 5.2.1.7.2 By Infusion Set

          3. 5.2.1.7.3 By Reservoir

        8. 5.2.1.8 Indonesia (Value and Volume, 2012-2024)

          1. 5.2.1.8.1 By Insulin Pump Device

          2. 5.2.1.8.2 By Infusion Set

          3. 5.2.1.8.3 By Reservoir

        9. 5.2.1.9 Philippines (Value and Volume, 2012-2024)

          1. 5.2.1.9.1 By Insulin Pump Device

          2. 5.2.1.9.2 By Infusion Set

          3. 5.2.1.9.3 By Reservoir

        10. 5.2.1.10 Thailand (Value and Volume, 2012-2024)

          1. 5.2.1.10.1 By Insulin Pump Device

          2. 5.2.1.10.2 By Infusion Set

          3. 5.2.1.10.3 By Reservoir

        11. 5.2.1.11 Rest of Asia-Pacific (Value and Volume, 2012-2024)

          1. 5.2.1.11.1 By Insulin Pump Device

          2. 5.2.1.11.2 By Infusion Set

          3. 5.2.1.11.3 By Reservoir

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2012-2024)

    2. 6.2 Type-2 Diabetes Population (2012-2024)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Medtronic

      2. 7.1.2 Insulet

      3. 7.1.3 Roche

      4. 7.1.4 Animas

      5. 7.1.5 Tandem

      6. 7.1.6 Ypsomed

      7. 7.1.7 Cellnovo

    2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Roche

      2. 7.2.2 Animas

      3. 7.2.3 Medtronic

      4. 7.2.4 Others

  8. 8. MARKET OPPORTUNITES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The APAC Insulin Infusion Pumps Market market is studied from 2018 - 2026.

The APAC Insulin Infusion Pumps Market is growing at a CAGR of 0% over the next 5 years.

Medtronic, Ypsomed, Insulet are the major companies operating in APAC Insulin Infusion Pumps Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!